Challenges with Diagnosing Pulmonary Chronic GVHD in Children as Per the 2014 National Institutes of Health Consensus Criteria: Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium (PBMTC) 1202 Study

Geoff D.E. Cuvelier(CancerCare Manitoba), Kirk R. Schultz(University of British Columbia), Michael A. Pulsipher(Primary Children's Hospital), Cori Abikoff(New York Medical College), Alexandra Cheerva(Kosair Children's Hospital), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Süreyya Savaşan(Children's Hospital of Michigan), Andrew C. Harris(Primary Children's Hospital), Emi Caywood(Alfred I. duPont Hospital for Children), Michael Joyce, Monica Bhatia(Columbia University Irving Medical Center), Eneida R. Nemecek(Oregon Health & Science University), Anat Halevy(University of British Columbia), Tal Schechter(Hospital for Sick Children), Justin T. Wahlstrom(University of California, San Francisco), Victor Lewis(Alberta Children's Hospital), Sung Won Choi(University of Michigan), Carrie L. Kitko(Vanderbilt University Medical Center), David A. Jacobsohn(Children's National), Albert Kerhadpour(Loma Linda University Medical Center), Sonali Chaudhury(Northwestern University), Anna Pawłowska(City of Hope), Joseph H. Chewning(Kettering University), David Mitchell(Montreal Children's Hospital), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Gail Megason(University of Mississippi Medical Center), Aleksandra Petrović(Seattle Children's Hospital), Donald W. Coulter(University of Nebraska Medical Center)
Transplantation and Cellular Therapy
February 22, 2017
Cited by 0


Related Papers